Thomas R et al. (2013) J Med Microbiol "Stenotrophomonas maltophilia: pathogenesis model using Caenorhabditis elegans."

Neela V, Thomas R, Hamat RA

[J Med Microbiol, 2013]

Stenotrophomonas maltophilia plays an important role as an opportunistic pathogen in immunocompromised individuals. Despite its clinical implication, the true knowledge regarding the pathogenicity of these bacteria remains unclear. Various methods have been employed to prove this bacterium to be pathogenic. However, the debate whether S. maltophilia is a true pathogen or a colonizer still remains unanswered as effective killing was not seen in earlier experiments with different animal models of infection (Denton et al., 1998; Adamak et al., 2011; Pompilo et al., 2011). Study by Rouf et al. (2011) on murine lung infection model illustrated that different strains of mice exhibited different outcome for S. maltophilia infection. Strains such as A/J and DBA/2 were permissive for clinical isolates of S. maltophilia and showed higher levels of pro-inflammatory cytokines. In contrast, BALB/c and C57BL/6 strains were non-permissive for S. maltophilia. While Huang et al. (2009) showed nematotoxic activity by environmental S. maltophilia strain against free-living nematode, Panagrellus redivivus, and plant-parasitic nematode, Bursaphelenchus xylophilus.

Clark IE et al. (2006) Nature "Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin."

Clark IE, Huh JR, Cao JH, Guo M, Jiang C, Yoo SJ, Dodson MW, Seol JH, Hay BA

[Nature, 2006]

Parkinson''s disease is the second most common neurodegenerative disorder and is characterized by the degeneration of dopaminergic neurons in the substantia nigra. Mitochondrial dysfunction has been implicated as an important trigger for Parkinson''s disease-like pathogenesis because exposure to environmental mitochondrial toxins leads to Parkinson''s disease-like pathology. Recently, multiple genes mediating familial forms of Parkinson''s disease have been identified, including PTEN-induced kinase 1 (PINK1; PARK6) and parkin (PARK2), which are also associated with sporadic forms of Parkinson''s disease. PINK1 encodes a putative serine/threonine kinase with a mitochondrial targeting sequence. So far, no in vivo studies have been reported for pink1 in any model system. Here we show that removal of Drosophila PINK1 homologue (CG4523; hereafter called pink1) function results in male sterility, apoptotic muscle degeneration, defects in mitochondrial morphology and increased sensitivity to multiple stresses including oxidative stress. Pink1 localizes to mitochondria, and mitochondrial cristae are fragmented in pink1 mutants. Expression of human PINK1 in the Drosophila testes restores male fertility and normal mitochondrial morphology in a portion of pink1 mutants, demonstrating functional conservation between human and Drosophila Pink1. Loss of Drosophila parkin shows phenotypes similar to loss of pink1 function. Notably, overexpression of parkin rescues the male sterility and mitochondrial morphology defects of pink1 mutants, whereas double mutants removing both pink1 and parkin function show muscle phenotypes identical to those observed in either mutant alone. These observations suggest that pink1 and parkin function, at least in part, in the same pathway, with pink1 functioning upstream of parkin. The role of the pink1-parkin pathway in regulating mitochondrial function underscores the importance of mitochondrial dysfunction as a central mechanism of Parkinson''s disease pathogenesis.

Van Gerven N et al. (2008) FEMS Microbiol Lett "Expression of in vivo-inducible Salmonella enterica promoters during infection of Caenorhabditis elegans."

Derous V, Hernalsteens JP, Van Gerven N

[FEMS Microbiol Lett, 2008]

In vitro mimicking of the stimuli controlling in vivo-inducible bacterial promoters during infection of the host can be complex. Therefore, the use of the nematode Caenorhabditis elegans was evaluated, as a surrogate host to examine the expression of Salmonella enterica promoters. Green fluorescent protein (GFP+) was put under the control of the promoters of the pagC, mgtB, sseA, pgtE and fur genes of S. enterica. After infection of C. elegans with an S. enterica serovar Typhimurium vaccine strain expressing these constructs, clear bacterial expression of GFP+ was observed under the control of all five promoters, although significant expression was not always obtained in vitro. It is concluded that C. elegans constitutes a useful model system for the study of the in vivo expression of Salmonella promoters.

Park J et al. (2006) Nature "Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin."

Kim J, Park J, Bae E, Shong M, Kim JM, Lee SB, Kim Y, Song S, Lee S, Kim S, Chung J

[Nature, 2006]

Autosomal recessive juvenile parkinsonism (AR-JP) is an early-onset form of Parkinson''s disease characterized by motor disturbances and dopaminergic neurodegeneration. To address its underlying molecular pathogenesis, we generated and characterized loss-of-function mutants of Drosophila PTEN-induced putative kinase 1 (PINK1), a novel AR-JP-linked gene. Here, we show that PINK1 mutants exhibit indirect flight muscle and dopaminergic neuronal degeneration accompanied by locomotive defects. Furthermore, transmission electron microscopy analysis and a rescue experiment with Drosophila Bcl-2 demonstrated that mitochondrial dysfunction accounts for the degenerative changes in all phenotypes of PINK1 mutants. Notably, we also found that PINK1 mutants share marked phenotypic similarities with parkin mutants. Transgenic expression of Parkin markedly ameliorated all PINK1 loss-of-function phenotypes, but not vice versa, suggesting that Parkin functions downstream of PINK1. Taken together, our genetic evidence clearly establishes that Parkin and PINK1 act in a common pathway in maintaining mitochondrial integrity and function in both muscles and dopaminergic neurons.